Patient ID: c5f1025e-36c9-41b5-39e7-5484599988b7
Name: Rey54 O'Conner199
Gender: male
Birth Date: 1928-03-02
Conditions: Serving in military service (finding); Educated to high school level (finding); Essential hypertension (disorder); Prediabetes (finding); Body mass index 30+ - obesity (finding); Anemia (disorder); Has a criminal record (finding); Localized, primary osteoarthritis of the hand (disorder); Full-time employment (finding); Metabolic syndrome X (disorder); Stress (finding); Medication review due (situation); Part-time employment (finding); Social isolation (finding); Medication review due (situation); Full-time employment (finding); Part-time employment (finding); Stress (finding); Viral sinusitis (disorder); Myocardial infarction (disorder); Acute non-ST segment elevation myocardial infarction (disorder); History of myocardial infarction (situation); Chronic kidney disease stage 1 (disorder); Disorder of kidney due to diabetes mellitus (disorder); Unemployed (finding); Gingivitis (disorder); Medication review due (situation); Part-time employment (finding); Stress (finding); Acute infective cystitis (disorder); Chronic kidney disease stage 2 (disorder); Microalbuminuria due to type 2 diabetes mellitus (disorder); Gingivitis (disorder); Medication review due (situation); Chronic kidney disease stage 3 (disorder); Proteinuria due to type 2 diabetes mellitus (disorder); Unemployed (finding); Gingivitis (disorder); Gingival disease (disorder); Medication review due (situation); Part-time employment (finding); Medication review due (situation); Not in labor force (finding); Stress (finding); Medication review due (situation); Part-time employment (finding); Gingivitis (disorder); Full-time employment (finding); Medication review due (situation); Stress (finding); Part-time employment (finding); Medication review due (situation); Not in labor force (finding); Suspected prostate cancer (situation); Full-time employment (finding); Medication review due (situation); Gingival disease (disorder); Laceration - injury (disorder); Laceration of forearm (disorder); Medication review due (situation); Social isolation (finding); Stress (finding); Part-time employment (finding); Gingivitis (disorder); Medication review due (situation); Suspected prostate cancer (situation); Neoplasm of prostate (disorder); Carcinoma in situ of prostate (disorder); Full-time employment (finding); Gingivitis (disorder); Chronic kidney disease stage 4 (disorder); Awaiting transplantation of kidney (situation); Fracture of bone (disorder); Fracture of rib (disorder); Gingivitis (disorder); Medication review due (situation); Stress (finding)
Medications: Naproxen sodium 220 MG Oral Tablet; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; aspirin 81 MG Oral Tablet; metoprolol tartrate 50 MG Oral Tablet; atorvastatin 40 MG Oral Tablet; losartan potassium 50 MG Oral Tablet; prasugrel 10 MG Oral Tablet; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; ciprofloxacin 500 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; Meperidine Hydrochloride 50 MG Oral Tablet; Naproxen sodium 220 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet; insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Humulin]; Hydrochlorothiazide 25 MG Oral Tablet; lisinopril 10 MG Oral Tablet
